SS
OYST

Steve Schonfeld’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Steve Schonfeld’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-17,000
Closed -$491K – 1763
2020
Q2 		$491K Buy
+17,000
New +$512K 0.01% 809

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KXA
KPCB XIV Associates Menlo Park, California $42.8M AUM 16.52% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Steve Schonfeld's OYST Position: Q3 2020 in Review

Steve Schonfeld sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q3 2020, closing a stake of 17,000 shares — an estimated $491K sold.

Steve Schonfeld first reported a position in OYST in Q2 2020 and held it in 1 quarter. The position peaked at $491K in Q2 2020. 66 funds tracked by Wall St. Rank hold OYST as of Q3 2020.

  • Steve Schonfeld reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Steve Schonfeld sold 17,000 Oyster Point Pharma, Inc. Common Stock shares in Q3 2020, an estimated $491K.
  • Steve Schonfeld first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Steve Schonfeld's Oyster Point Pharma, Inc. Common Stock position peaked at $491K in Q2 2020.
  • 66 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q3 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.